AXON Stock Analysis: Axon Enterprise | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 34.506m USD | 12M Return: -42% | US05464C1018 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 453M
EPS Trend: 85.3%
Qual. Beats: 0
Rev. Trend: 100.0%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Axon Enterprise, Inc. (NASDAQ: AXON) is a U.S.-based public safety technology company headquartered in Scottsdale, Arizona, operating through two main segments: Software and Services, and Connected Devices. The Software and Services segment offers cloud-based SaaS platforms for capturing, storing, and analyzing digital evidence, including products such as Axon Evidence, Draft One, Axon Records, and Axon Fusus. The Connected Devices segment produces hardware such as TASER conducted energy devices, body-worn and in-car cameras, drone and counter-drone systems, and virtual reality training equipment.
The company sells to a diverse customer base that includes federal, state, and local law enforcement agencies, international government entities, commercial enterprises, and consumers, using a mix of direct sales, distribution partners, and third-party resellers. Originally incorporated in 1993 and formerly known as TASER International, the company rebranded to Axon Enterprise in April 2017 to reflect its expansion beyond conducted energy weapons into a broader integrated software and hardware ecosystem for first responders.
Axon is classified under the GICS Industrials sector and Aerospace & Defense sub-industry, though its primary end market is law enforcement and public safety rather than traditional military defense. A key feature of its business model is the recurring revenue generated through its SaaS subscriptions and evidence-management platforms, which complement the one-time hardware sales of TASER devices and cameras and support customer retention across agency lifecycles.
- Software and Services segment drives recurring revenue growth
- TASER and body camera demand strengthens from US law enforcement
- International expansion and drone counter-drone adoption accelerate
- Federal and state government budget cycles impact order timing
| Net Income: 199.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.06 > 1.0 |
| NWC/Revenue: 49.90% < 20% (prev 105.8%; Δ -55.94% < -1%) |
| CFO/TA 0.04 > 3% & CFO 265.8m > Net Income 199.6m |
| Net Debt (1.24b) to EBITDA (477.5m): 2.60 < 3 |
| Current Ratio: 2.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (82.5m) vs 12m ago 0.56% < -2% |
| Gross Margin: 59.41% > 18% (prev 60.47%; Δ -1.06% > 0.5%) |
| Asset Turnover: 47.01% > 50% (prev 38.48%; Δ 8.53% > 0%) |
| Interest Coverage Ratio: 3.22 > 6 (EBIT TTM 368.1m / Interest Expense TTM 114.5m) |
| A: 0.21 (Total Current Assets 3.00b - Total Current Liabilities 1.40b) / Total Assets 7.48b |
| B: 0.15 (Retained Earnings 1.14b / Total Assets 7.48b) |
| C: 0.05 (EBIT TTM 368.1m / Avg Total Assets 6.85b) |
| D: 0.97 (Book Value of Equity 3.67b / Total Liabilities 3.81b) |
| Altman-Z'' = 3.28 = A |
| DSRI: 0.52 (Receivables 768.6m/1.09b, Revenue 3.22b/2.39b) |
| GMI: 1.02 (GM 60.47% / 59.41%) |
| AQI: 1.62 (AQ_t 0.55 / AQ_t-1 0.34) |
| SGI: 1.35 (Revenue 3.22b / 2.39b) |
| TATA: -0.01 (NI 199.6m - CFO 265.8m) / TA 7.48b) |
| Beneish M = -2.79 (Cap -4..+1) = A |
As of October 08, 2026, the stock is trading at USD 406.00 with a total of 922,437 shares traded. Over the past week, the price has changed by -0.23%, over one month by -17.18%, over three months by -32.74% and over the past year by -41.99%.
Current recommended Stop Loss: 353.80 (which is 12.9% or 2.5 ATR below the current price).
Axon Enterprise has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy AXON.
- StrongBuy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 704.1 | 73.4% |
P/E Trailing = 175.5165
P/E Forward = 58.1395
P/S = 10.719
P/B = 10.1547
P/EG = 2.1074
Revenue TTM = 3.22b USD
EBIT TTM = 368.1m USD
EBITDA TTM = 477.5m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 80.6m USD (from shortTermDebt, last fiscal year)
Debt = 1.94b USD (from shortLongTermDebtTotal, last quarter) + Leases 101.7m
Net Debt = 1.24b USD (calculated: Debt 1.94b - CCE 692.5m)
Enterprise Value = 35.7b USD (34.5b + Debt 1.94b - CCE 692.5m)
Interest Coverage Ratio = 3.22 (Ebit TTM 368.1m / Interest Expense TTM 114.5m)
EV/FCF = 268.4x (Enterprise Value 35.7b / FCF TTM 133.2m)
FCF Yield = 0.37% (FCF TTM 133.2m / Enterprise Value 35.7b)
FCF Margin = 4.14% (FCF TTM 133.2m / Revenue TTM 3.22b)
Net Margin = 6.20% (Net Income TTM 199.6m / Revenue TTM 3.22b)
Gross Margin = 59.41% ((Revenue TTM 3.22b - Cost of Revenue TTM 1.31b) / Revenue TTM)
Gross Margin QoQ = 60.42% (prev 59.12%)
Tobins Q-Ratio = 4.78 (Enterprise Value 35.7b / Total Assets 7.48b)
Interest Expense / Debt = 5.92% (Interest Expense 114.5m / Debt 1.94b)
Taxrate = 21.31% (54.1m / 253.6m)
NOPAT = 289.6m (EBIT 368.1m * (1 - 21.31%))
Current Ratio = 2.15 (Total Current Assets 3.00b / Total Current Liabilities 1.40b)
Debt / Equity = 0.53 (Debt 1.94b / totalStockholderEquity, last quarter 3.67b)
Debt / EBITDA = 2.60 (Net Debt 1.24b / EBITDA 477.5m)
Debt / FCF = 9.33 (Net Debt 1.24b / FCF TTM 133.2m)
Total Stockholder Equity = 3.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.91% (Net Income 199.6m / Total Assets 7.48b)
RoE = 5.92% (Net Income TTM 199.6m / Total Stockholder Equity 3.37b)
RoCE = 7.22% (EBIT 368.1m / Capital Employed (Equity 3.37b + L.T.Debt 1.73b))
RoIC = 4.83% (NOPAT 289.6m / Invested Capital 6.00b)
WACC = 10.45% (E(34.5b)/V(36.4b) * Re(10.78%) + D(1.94b)/V(36.4b) * Rd(5.92%) * (1-Tc(0.21)))
Discount Rate = 10.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 51.13 | Cagr: 3.05%
[DCF] Terminal Value 65.66% ; FCFF base≈150.5m ; Y1≈132.0m ; Y5≈106.6m
[DCF] Fair Price = 0.37 (EV 1.27b - Net Debt 1.24b = Equity 30.3m / Shares 81.2m; r=10.45% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 85.31 | EPS CAGR: 24.08% | SUE: 0.75 | # QB: 0
Revenue Correlation: 99.98 | Revenue CAGR: 33.09% | SUE: 2.37 | # QB: 3
EPS current Quarter (2026-09-30): EPS=1.95 | Chg30d=-0.69% | Revisions=-24% | Analysts=17
EPS current Year (2026-12-31): EPS=7.65 | Chg30d=-0.78% | Revisions=+32% | GrowthEPS=+11.7% | GrowthRev=+33.3%
EPS next Year (2027-12-31): EPS=10.54 | Chg30d=-0.15% | Revisions=+35% | GrowthEPS=+37.8% | GrowthRev=+29.3%
[Analyst] Revisions Ratio: +18% (up=28, down=19)